Breast cancer - gemcitabine
Gemcitabine for the treatment of metastatic breast cancer
Summary
Gemcitabine, which is combined with another medicine called paclitaxel to treat metastatic breast cancer, is only recommended as a possible treatment for people with metastatic breast cancer in situations where two other treatments could also be used as alternatives. Other treatments that doctors co ...
Guidance documents
Implementing this guidance
We will consult on our review plans for this guidance in January 2010
About this guidance
Technology appraisals TA116
Issued: January 2007
